Clinical Trials Directory

Trials / Completed

CompletedNCT03288727

Secondary Findings From High-throughput Sequencing: How to Announce Them With Respect to the Patient's Needs

Incidental Findings Produced by Diagnostic HTS: From the Needs of Patients to Organisational Considerations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
342 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

High-throughput whole-genome sequencing (WGS) is bringing new opportunities in the diagnosis of rare diseases. It will more frequently lead to a primary diagnosis (aim of the genetic consultation), but it may also lead to the discovery of mutations not related to the patient's disease. These findings are called "incidental findings" (IF) and may give rise to preventive or curative interventions in a personalised medicine approach. The question of proposing to patients access to all or part of these findings is a matter of debate in France and elsewhere. This question has given rise to new challenges and new needs that professionals must respond to by implementing appropriate management and new skills. It raises specific ethical issues, which require precise understanding of the expectations and experiences of patients. Patients' diagnostic trajectories must also meet criteria for efficacy and financial and organisational sustainability for the healthcare establishments and, for the healthcare system. Our project aims to assess the expectations of patients/parents with regard to this opportunity, and to determine how information should be provided to patients and how they should be accompanied to ensure efficient and appropriate management.

Conditions

Interventions

TypeNameDescription
OTHERinterviews with a psychologistan interview with a psychologist / sociologist will take place after completion of the on-site questionnaires to find out the reasons for their choice of accessing their secondary data and their experiences with the secondary data reported.

Timeline

Start date
2017-11-13
Primary completion
2021-11-24
Completion
2021-11-24
First posted
2017-09-20
Last updated
2022-09-14

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03288727. Inclusion in this directory is not an endorsement.